<DOC>
	<DOCNO>NCT01919996</DOCNO>
	<brief_summary>This Post-Authorization Safety Study ( PASS ) intend fulfill regulatory post-marketing requirement provide data regard visual ability child take azithromycin ( immediate-release formulation ) acute pharyngitis/tonsillitis . The primary objective study examine incidence clinically significant worsen follow ophthalmic exam : best correct visual acuity ( distance ) , color vision , Amsler grid testing , anterior segment biomicroscopy , fundus examination , group approximately 30 pediatric patient take azithromycin oral solution treatment authorize indication use ( pharyngitis/ tonsillitis ) .</brief_summary>
	<brief_title>PASS Study To Evaluate The Potential Of Zithromax To Cause Ocular Problems In Pediatric Patients</brief_title>
	<detailed_description>Study terminate prematurely October 16 , 2015 follow FDA decision release Sponsor post-marketing commitment . No safety and/or efficacy concern identify .</detailed_description>
	<mesh_term>Pharyngitis</mesh_term>
	<mesh_term>Tonsillitis</mesh_term>
	<criteria>Male female patient , age 12 17 year . Requires outpatient treatment acute pharyngitis/tonsillitis infection . Appropriate treat oral azithromycin alternative intramuscular penicillin , opinion investigator . Positive rapid antigen detection test . History clinically significant eye disorder would interfere protocol test procedure . Hypersensitivity azithromycin , erythromycin , macrolide , ketolide antibiotic . Increased risk QT prolongation . Pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Ocular safety</keyword>
	<keyword>azithromycin</keyword>
	<keyword>pharyngitis</keyword>
	<keyword>tonsillitis</keyword>
</DOC>